Literature DB >> 17413409

Risks of malignancy in inverted papilloma of the nose and paranasal sinuses.

Christian von Buchwald1, Patrick J Bradley.   

Abstract

PURPOSE OF REVIEW: The majority of inverted nasal papilloma are benign and treatment is by complete local surgical removal. There is an associated real, but small risk of malignancy, which may coexist at the time of presentation or develop at a later time. This article reviews some of the recent publications addressing the association of inverted papilloma with malignancy. RECENT
FINDINGS: Neither the etiology of inverted papilloma nor the factors responsible for malignant transformation are fully elucidated to date. Inverted papilloma is associated with squamous cell carcinoma in approximately 10% of the cases. Malignancy may occur synchronously or metachronously.
SUMMARY: Based on the literature, the rates of synchronous and metachronous carcinoma are 7.1 and 3.6%, respectively, although rates may be exaggerated due to a referral bias to tertiary centres. A thorough removal of all diseased mucosa is curative and a meticulous histological examination of the entire specimen is necessary. The working risk is approximately 10%. Recurrent disease and metachronous carcinoma can develop after a prolonged period of time. As most recurrences are due to incomplete resection, it is mandatory to perform a close follow-up, with biopsies performed when indicated. Life-long follow-up is recommended.

Entities:  

Mesh:

Year:  2007        PMID: 17413409     DOI: 10.1097/MOO.0b013e3280803d9b

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  28 in total

1.  Evaluation of p53, p63, p21, p27, ki-67 in paranasal sinus squamous cell carcinoma and inverted papilloma.

Authors:  Semih Oncel; Tulin Cosgul; Aylin Calli; Caglar Calli; Ercan Pinar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-11

2.  Inverted papilloma: a clinico-pathological dilemma with special reference to recurrence and malignant transformation.

Authors:  S N Saha; Anirban Ghosh; Sharmila Sen; S Chandra; Debabrata Biswas
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-01

3.  The role of tissue factor pathway inhibitor-2 in malignant transformation of sinonasal inverted papilloma.

Authors:  Huapeng Yu; Quan Liu; Huan Wang; Dehui Wang; Li Hu; Xicai Sun; Juan Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-07       Impact factor: 2.503

4.  Factors affecting recurrence of sinonasal inverted papilloma.

Authors:  Wang Xiao-Ting; Li Peng; Wei Xiu-Qing; Wang Hai-Bo; Pang Wen-Hui; Li Bing; Zhang Er-Peng; Shi Guang-Gang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-12       Impact factor: 2.503

5.  Fascin over expression is associated with dysplastic changes in sinonasal inverted papillomas: a study of 47 cases.

Authors:  Hope H Wu; Samiah Zafar; Youming Huan; Herman Yee; Luis Chiriboga; Beverly Y Wang
Journal:  Head Neck Pathol       Date:  2009-08-14

Review 6.  Common head and neck cases in our consultation referrals: diagnostic dilemmas in inverted papilloma.

Authors:  Ann Sandison
Journal:  Head Neck Pathol       Date:  2009-08-20

7.  Immunohistochemical Study EMT-Related Proteins in HPV-, and EBV-Negative Patients with Sinonasal Tumours.

Authors:  Olga Stasikowska-Kanicka; Małgorzata Wągrowska-Danilewicz; Marian Danilewicz
Journal:  Pathol Oncol Res       Date:  2016-04-30       Impact factor: 3.201

Review 8.  Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review.

Authors:  M Re; F M Gioacchini; A Bajraktari; M Tomasetti; S Kaleci; C Rubini; A Bertini; G Magliulo; E Pasquini
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-21       Impact factor: 2.503

9.  Squamous Cell Carcinoma Arising from Sinonasal Inverted Papilloma.

Authors:  D T Ginat; A Trzcinska; P Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

10.  Transitional neoplasms of the naso-lacrimal system: A review of the histopathology and histogenesis.

Authors:  J Godfrey Heathcote
Journal:  Saudi J Ophthalmol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.